血清标志物对社区获得性肺炎的诊断及预后的影响  

Effect of serum markerson the diagnosis and prognosis of community acquired pneumonia

作　　者：张楠[1] 朱华栋[1] Zhang Nan;Zhu Hua-dong(Department of Emergency,Peking Union Medical College Hospital,Beijing 100730,China)

机构地区：[1]北京协和医学院,中国医学科学院,北京协和医院急诊科,北京100730

出　　处：《中国急救医学》2019年第1期82-87,共6页Chinese Journal of Critical Care Medicine

摘　　要：社区获得性肺炎目前仍是发达国家和发展中国家的主要死亡原因,早期发现社区获得性肺炎(community-acquired pneumonia,CAP)患者预后不良风险是减少病死率的关键,其可能对医疗资源的消耗及后续治疗产生影响。目前多采用评分系统预测CAP患者的预后,但存在一定局限性,当前多项研究表明,多种血清标志物在CAP诊断、预后评估及治疗中均具有重要意义。本文旨在总结近年来针对CAP患者的诊断和预后有影响价值的相关血清标志物。Community acquired pneumonia(CAP)is still the main cause of death in developed and developing countries.Early detection of poor prognosis for patients is the key to treatment and may affect the consumption and prognosis of medical resources.At present,scoring criteria are widely used to predict the risk of death,but there are some limitations.In recent years,many studies have shown that serum markers are effective right tools for the diagnosis,prognosis and subsequent treatment of community acquired pneumonia.The purpose of this paper is to summarize the relevant serum markers that have an impact on the diagnosis and prognosis of patients with community-acquired pneumonia in recent years.

关 键 词：社区获得性肺炎(CAP) 降钙素原 C-反应蛋白 D-二聚体(D_Dimer) 中性粒细胞百分比(NCP) 中性粒细胞/淋巴细胞比值(NLR) 白-细胞介素-6(IL-6) 

分 类 号：R563.1[医药卫生—呼吸系统]